CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT
Alpha crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the sp...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SOUVIE Jean-Claude LEFEBVRE Loic AUTHOUART Pascale COQUEREL Gerard |
| description | Alpha crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Alpha crystalline form of perindopril arginine salt of formula (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Independent claims are included for: (1) a composition comprising (I) in combination with inert and nontoxic vehicles; and (2) the preparation of (I). [Image] ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor. No biological data given. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI1989182TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI1989182TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI1989182TT13</originalsourceid><addsrcrecordid>eNqNi7EOwjAMRLswIOAfzF6GwgKjlaatpTSJbDMwVRUKE4JKZeXfocAHMN3du7t59jR8EkXnyFuoArcQKtDGAnJNfoKCTicYLZMvQ2RyOUQOxopMj7e3Ed9dDaQ5oC8hNsgtGntUMujAhDYGIaXg5ROY5DtfZrNLfx3T6qeLbF1ZNc0mDfcujUN_Trf06ISKw_5Q7Leqxe6fzQvLEDwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT</title><source>esp@cenet</source><creator>SOUVIE Jean-Claude ; LEFEBVRE Loic ; AUTHOUART Pascale ; COQUEREL Gerard</creator><creatorcontrib>SOUVIE Jean-Claude ; LEFEBVRE Loic ; AUTHOUART Pascale ; COQUEREL Gerard</creatorcontrib><description>Alpha crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Alpha crystalline form of perindopril arginine salt of formula (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Independent claims are included for: (1) a composition comprising (I) in combination with inert and nontoxic vehicles; and (2) the preparation of (I). [Image] ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor. No biological data given.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160729&DB=EPODOC&CC=SI&NR=1989182T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160729&DB=EPODOC&CC=SI&NR=1989182T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SOUVIE Jean-Claude</creatorcontrib><creatorcontrib>LEFEBVRE Loic</creatorcontrib><creatorcontrib>AUTHOUART Pascale</creatorcontrib><creatorcontrib>COQUEREL Gerard</creatorcontrib><title>CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT</title><description>Alpha crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Alpha crystalline form of perindopril arginine salt of formula (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Independent claims are included for: (1) a composition comprising (I) in combination with inert and nontoxic vehicles; and (2) the preparation of (I). [Image] ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor. No biological data given.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EOwjAMRLswIOAfzF6GwgKjlaatpTSJbDMwVRUKE4JKZeXfocAHMN3du7t59jR8EkXnyFuoArcQKtDGAnJNfoKCTicYLZMvQ2RyOUQOxopMj7e3Ed9dDaQ5oC8hNsgtGntUMujAhDYGIaXg5ROY5DtfZrNLfx3T6qeLbF1ZNc0mDfcujUN_Trf06ISKw_5Q7Leqxe6fzQvLEDwA</recordid><startdate>20160729</startdate><enddate>20160729</enddate><creator>SOUVIE Jean-Claude</creator><creator>LEFEBVRE Loic</creator><creator>AUTHOUART Pascale</creator><creator>COQUEREL Gerard</creator><scope>EVB</scope></search><sort><creationdate>20160729</creationdate><title>CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT</title><author>SOUVIE Jean-Claude ; LEFEBVRE Loic ; AUTHOUART Pascale ; COQUEREL Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI1989182TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SOUVIE Jean-Claude</creatorcontrib><creatorcontrib>LEFEBVRE Loic</creatorcontrib><creatorcontrib>AUTHOUART Pascale</creatorcontrib><creatorcontrib>COQUEREL Gerard</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SOUVIE Jean-Claude</au><au>LEFEBVRE Loic</au><au>AUTHOUART Pascale</au><au>COQUEREL Gerard</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT</title><date>2016-07-29</date><risdate>2016</risdate><abstract>Alpha crystalline form of perindopril arginine salt (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Alpha crystalline form of perindopril arginine salt of formula (I), characterized by the X-ray diffraction diagram on powder, measured by a diffractometer (copper anticathode) and exhibited a Bragg angle 2 theta, an interreticular distance (d), an intensity and a relative intensity, as given in table of the specification, is new. Independent claims are included for: (1) a composition comprising (I) in combination with inert and nontoxic vehicles; and (2) the preparation of (I). [Image] ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor. No biological data given.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI1989182TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T17%3A51%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SOUVIE%20Jean-Claude&rft.date=2016-07-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI1989182TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |